Low dose olanzapine in non-inferior to standard dose in terms of anti-emetic effect in patients receiving emetogenic chemotherapy

1. Low dose Olanzapine (2.5 mg) demonstrated similar anti-emetic effect to standard dose olanzapine in patients receiving emetogenic chemotherapy 2. Patients in the low-dose group experienced significantly fewer instances of daytime somnolence compared to those who received standard dose Evidence Rating Level: 1 (Excellent) Study Rundown: The present trial was a single-centered trial that compared […]

The post Low dose olanzapine in non-inferior to standard dose in terms of anti-emetic effect in patients receiving emetogenic chemotherapy first appeared on 2 Minute Medicine.